Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 3270 entries
View as:

Time Required to Dissolve Urate Deposits

Phase: N/A Priority: Normal
NCT ID: NCT06669000 Org: User:
Start: 11/30/24 End: 11/30/32 Due: 11/30/33

Evaluation of Therapeutic Hypothermia in Convulsive Status EPILEPTICUS in Adults in Intensive Care

Phase: N/A Priority: Normal
NCT ID: NCT01359332 Org: User:
Start: 12/31/10 End: 08/31/16 Due: 08/31/17

New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase Δ Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06694363 Org: User:
Start: 12/31/24 End: 05/31/29 Due: 05/31/30

Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)

Phase: N/A Priority: Normal
NCT ID: NCT02619630 Org: User:
Start: 12/31/15 End: 12/31/25 Due: 12/31/26

Sublingual Milk Immunotherapy in Children

Phase: N/A Priority: Normal
NCT ID: NCT00874627 Org: User:
Start: 09/30/08 End: 12/31/12 Due: 12/31/13

Transition From Paediatric Intensive Care to General Paediatrics and Pneumology Units : a Study of the Post-intensive Care Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT05587595 Org: User:
Start: 10/19/22 End: 03/01/24 Due: 03/01/25

Assessment of Cardiac Output in Patients With ARDS Implanted With Venous-venous ECMO.

Phase: N/A Priority: Normal
NCT ID: NCT05164484 Org: User:
Start: 01/19/21 End: 01/15/25 Due: 01/15/26

Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients with Covid-19. a G2i Study, National Multicenter Observational and Retrospective from June 2023 to April 2024

Phase: N/A Priority: Normal
NCT ID: NCT06683937 Org: User:
Start: 12/01/24 End: 06/01/25 Due: 06/01/26

Epidemiological, Clinical and Etiological Features of SUSAC's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01481662 Org: User:
Start: 11/30/11 End: 05/31/21 Due: 05/31/22

Effects of Light-therapy in Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02686190 Org: User:
Start: 07/31/12 End: 12/31/14 Due: 12/31/15

Macrophages, GM-CSF and MARS Proteinosis

Phase: N/A Priority: Normal
NCT ID: NCT04811274 Org: User:
Start: 06/07/21 End: 11/06/21 Due: 11/06/22

Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06228352 Org: User:
Start: 03/31/25 End: 03/31/28 Due: 03/31/29

Anakinra and Kawasaki Disease

Phase: N/A Priority: Normal
NCT ID: NCT02390596 Org: User:
Start: 02/05/16 End: 02/18/19 Due: 02/18/20

TOward the Lowest Effective DOse of Abatacept or Tocilizumab

Phase: N/A Priority: Normal
NCT ID: NCT01557374 Org: User:
Start: 04/30/12 End: 11/08/19 Due: 11/08/20

Conservative Aortic Valve Surgery for Aortic Insufficiency and Aneurysms of the Aortic Root. CAVIAAR

Phase: N/A Priority: Normal
NCT ID: NCT00478803 Org: User:
Start: 05/31/07 End: 11/30/14 Due: 11/30/15

Prolactin Receptor and Breast Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00842465 Org: User:
Start: 09/30/08 End: 06/30/12 Due: 06/30/13

Validity of the French Version of Deafness Questionnaires for Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT04563884 Org: User:
Start: 10/04/20 End: 12/31/20 Due: 12/31/21

Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QT-IOP)

Phase: N/A Priority: Normal
NCT ID: NCT04167033 Org: User:
Start: 04/14/21 End: 04/13/24 Due: 04/13/25

MINI Bypass Versus Roux-en-Y Bypass: Differences in HOrmonal Secretions at 2 Years of Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03482895 Org: User:
Start: 04/04/18 End: 05/14/19 Due: 05/14/20

Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis

Phase: N/A Priority: Normal
NCT ID: NCT01731561 Org: User:
Start: 11/16/12 End: 04/05/16 Due: 04/05/17

Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2

Phase: N/A Priority: Normal
NCT ID: NCT06062303 Org: User:
Start: 02/06/24 End: 05/30/26 Due: 05/30/27

Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01086735 Org: User:
Start: 02/28/10 End: 11/30/12 Due: 11/30/13

Impact of Hypnosis During Invasive Procedure in Intensive Care Unit

Phase: N/A Priority: Normal
NCT ID: NCT04399850 Org: User:
Start: 09/28/20 End: 03/28/24 Due: 03/28/25

Validation Study of Posturology Platforms for Evaluating Postural Control of Hemiparetic and Neuro-muscular Patients

Phase: N/A Priority: Normal
NCT ID: NCT04283175 Org: User:
Start: 04/01/21 End: 02/09/24 Due: 02/09/25

Nintedanib Treatment in Unicentric Castleman Disease

Phase: N/A Priority: Normal
NCT ID: NCT06643091 Org: User:
Start: 11/01/24 End: 09/01/30 Due: 09/01/31